Agency Information Collection Activities; Proposals, Submissions, and Approvals: Infant Formula Requirements
Federal Register: May 4, 2010 (Volume 75, Number 85)
Notices
Page 23777-23779
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
DOCID:fr04my10-92
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket No. FDA-2010-N-0190
Agency Information Collection Activities; Proposed Collection;
Comment Request; Infant Formula Requirements
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of
Page 23778
information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection regarding the manufacture of infant formula, including infant formula labeling, quality control procedures, notification requirements, and recordkeeping.
DATES: Submit written or electronic comments on the collection of information by July 6, 2010.
ADDRESSES: Submit electronic comments on the collection of information to http://www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA- 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-3793.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document.
With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology.
Infant Formula Requirements--21 CFR Parts 106 and 107 (OMB Control
Number 0910-0256)--Extension
Statutory requirements for infant formula under the Federal Food,
Drug, and Cosmetic Act (the act) are intended to protect the health of infants and include a number of reporting and recordkeeping requirements. Among other things, section 412 of the act (21 U.S.C. 350a) requires manufacturers of infant formula to establish and adhere to quality control procedures, notify FDA when a batch of infant formula that has left the manufacturers' control may be adulterated or misbranded, and keep records of distribution. FDA has issued regulations to implement the act's requirements for infant formula in parts 106 and 107 (21 CFR parts 106 and 107). FDA also regulates the labeling of infant formula under the authority of section 403 of the act (21 U.S.C. 343). Under the labeling regulations for infant formula in part 107, the label of an infant formula must include nutrient information and directions for use. The purpose of these labeling requirements is to ensure that consumers have the information they need to prepare and use infant formula appropriately. In a notice of proposed rulemaking published in the Federal Register of July 9, 1996
(61 FR 36154), FDA proposed changes in the infant formula regulations, including some of those listed in tables 1, 2, and 3 of this document.
The document included revised burden estimates for the proposed changes and solicited public comment. In the interim, however, FDA is seeking an extension of OMB approval for the current regulations so that it can continue to collect information while the proposal is pending.
FDA estimates the burden of this collection of information as follows:
Table 1.--Estimated Annual Reporting Burden\1\
Federal Food, Drug, and Cosmetic Act or 21 CFR
No. of
Annual Frequency
Total Annual
Hours per
Section
Respondents
per Response
Responses
Response
Total Hours
Section 412(d) of the act
5
13
65
10
650
1
1
1
4
4
21 CFR 107.50(b)(3) and (b)(4)
3
2
6
4
24
1
1
1
4
4
Total
682
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 2.--Estimated Annual Recordkeeping Burden\1\
21 CFR
No. of
Annual Frequency
Total Annual
Section
Recordkeepers per Recordkeeping
Records
Hours per Record
Total Hours
106.100
5
10
50
400
20,000
107.50
3
10
30
300
9,000
(c)(3)
Page 23779
Total
29,000
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
Table 3.--Third Party Disclosure Requirements\1\
21 CFR
No. of
Annual Frequency
Total Annual
Hours per
Section
Respondents
of Disclosure
Disclosures
Disclosure
Total Hours
21 CFR
5
13
65
8
520 107.10(a) and 107.20
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information
In compiling these estimates, FDA consulted its records of the number of infant formula submissions received in the past. All infant formula submissions to FDA may be provided in electronic format. The hours per response reporting estimates are based on FDA's experience with similar programs and information received from industry.
FDA estimates that it will receive 13 reports from 5 manufacturers annually under section 412(d) of the act, for a total annual response of 65 reports. Each report is estimated to take 10 hours per response for a total of 650 hours. FDA also estimates that it will receive one notification under Sec. 106.120(b). The notification is expected to take 4 hours per response, for a total of 4 hours.
For exempt infant formula, FDA estimates that it will receive two reports from three manufacturers annually under Sec. 107.50(b)(3) and
(b)(4), for a total annual response of six reports. Each report is estimated to take 4 hours per response for a total of 24 hours. FDA also estimates that it will receive one notification under Sec. 107.50(e)(2). The notification is expected to take 4 hours per response, for a total of 4 hours.
FDA estimates that 5 firms will expend approximately 20,000 hours per year to fully satisfy the record keeping requirements in Sec. 106.100. It is estimated that 3 firms will expend approximately 9,000 hours per year to fully satisfy the record keeping requirements in
Sec. 107.50(c)(3).
FDA estimates that compliance with the labeling requirements of
Sec. Sec. 107.10(a) and 107.20 will require 520 hours annually by 5 manufacturers.
Dated: April 28, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
FR Doc. 2010-10360 Filed 5-3-10; 8:45 am
BILLING CODE 4160-01-S
